Interview with CEO and Co-Founder of SMSbiotech, Dr. Abdulkader Rahmo

About BioNeex | BioNeex is the first open exchange platform for R&D-stage licensing and collaborative partnerships in the biopharmaceutical industry. At BioNeex we work together with research institutions, biotechnology and biopharmaceutical companies that are discovering and developing innovative compounds by connecting them through our online biopharma R&D exchange platform. Helping our clients to gain for their compounds a vital exposure to the right partners at the right time will increase the likelihood to get these innovative compounds into the clinic and, ultimately, to the patients as novel medicines. In essence, BioNeex provides an online infrastructure for biopharmaceutical, biotech companies and research institutions, where they can meet and partner. The BioNeex Interviews simply are part of the BioNeex vision, which is providing exposure to biotech companies and their R&D pipelines in order to find the right licensing and co-development partners without spending lots of time and money on conferences. About SMSbiotech | SMSbiotech is a California, US-based biotech company developing therapeutics on stem cell technology. The company is also currently engaged in developing a COVID-19 treatment.